Keyphrases
Aberrations
24%
Bcl-2 Family
26%
Cas9 Protein
26%
Cell Population
26%
Cell-based
26%
Checkpoint Kinase 1 (CHK1)
26%
Chromosomal Deletion
26%
Chromosome 11q
33%
Chromosome 1q
26%
Cisplatin Resistance
53%
Differential Diagnosis
13%
Epigenetics
26%
Feeder-free Culture
26%
Genetic Aberrations
53%
Germ Cell Malignancy
26%
Germ Cell Tumor
65%
Heat Map
13%
Human Pluripotent Stem Cells (hPSCs)
53%
Large Cell Neuroendocrine Carcinoma (LCNEC)
13%
Large Deletion
26%
Leiomyosarcoma
20%
Loss Amplification
26%
Malignant Germ Cell Tumors
40%
Mediastinal Germ Cell Tumor
53%
MEK Inhibitor (MEKi)
33%
Murine Double Minute 4 (MDM4)
26%
MYCN Amplification
26%
NCCIT
16%
Neuroblastoma
100%
Neuroblastoma Cell Line
22%
Pathway mutation
26%
Pediatric Cancer
26%
Pediatric Tumors
20%
Pluripotent
26%
Poor Outcome
26%
Primary Tumor
13%
RAS-MAPK
26%
RAS-MAPK Pathway
69%
Refractory Neuroblastoma
35%
Safety Issues
26%
Somatic Malignancy
26%
Synthetic Lethality
26%
Targeted Drugs
26%
Testicular Germ Cell Tumor
26%
Trametinib
21%
Tumor
42%
Tumor Progression
26%
Tumor Protein p53 (TP53)
37%
Tumor Risk
26%
Tumor Subtype
40%
Medicine and Dentistry
Biological Marker
12%
Biopsy Technique
6%
Cancer
26%
Carcinogenesis
8%
Cell Population
26%
Checkpoint Kinase 1
26%
Chemotherapy
10%
Chromosome 11q
26%
Cisplatin
53%
Critical Appraisal
6%
Diabetes Mellitus
8%
Diagnosis
13%
Differential Diagnosis
6%
Disease
35%
Ganglioneuroblastoma
53%
Germinoma
70%
Heat Map
13%
High Throughput Screening
5%
Human Pluripotent Stem Cell
17%
In Vitro
10%
Infancy
8%
Intracranial Tumor
6%
Knock Out
7%
Large Cell Neuroendocrine Carcinoma
6%
Leiomyosarcoma
10%
Lethality
26%
Malignant Neoplasm
24%
Malignant Transformation
8%
Mediastinal Germ Cell Tumor
38%
Medicine
8%
Mitogen-Activated Protein Kinase
26%
Neoplasm
82%
Neuroblastoma Cell Line
6%
Overall Survival
8%
Patient Experience
6%
Patient with Neuroblastoma
6%
Pediatric Cancer
26%
Pediatrics
13%
Pluripotent Stem Cell
26%
Primary Tumor
6%
Protein P53
11%
Recurrent Disease
26%
Risk Stratification
6%
Solid Malignant Neoplasm
12%
Somatic Mutation
6%
Somatics
26%
Stem Cell Therapy
26%
Systematic Review
6%
Tumor Suppressor Protein
6%
Whole Genome Sequencing
6%
Biochemistry, Genetics and Molecular Biology
Adolescence
13%
Alpha-Fetoprotein
13%
Autosome
6%
Carcinogenesis
8%
Chromosomal Aberration
8%
Chromosome 11q
40%
Chromosome 1q
26%
Chromosome 6q
13%
Cisplatin
53%
Clonal Evolution
6%
Clonal Variation
13%
Clonality
13%
Colony Forming Unit S
13%
CRISPR/Cas9
26%
Directed Differentiation
8%
DNA Methylation
13%
DNA Repair
8%
Functional Genomics
13%
Genetics
36%
Genomics
29%
Growth, Development and Aging
13%
High Throughput Screening
8%
Human Chorionic Gonadotropin
13%
Infancy
8%
Karyotyping
6%
Kinase
26%
Malignant Transformation
8%
MDM4
26%
Mitogen-Activated Protein Kinase
53%
Neuroendocrine Cell
26%
Overall Survival
11%
P53
20%
Phosphotransferase
26%
PHOX2B
6%
Polyploid
13%
Preclinical Study
8%
Prevalence
6%
RNA Sequence
13%
Somatic Mutation
6%
Stem Cell
26%
Stem Cell Culture
6%
Stem Cell Transplantation
26%
Survival Rate
8%
Tumor Marker
13%
Tumor Progression
26%
Tumor Suppressor Protein
6%
Vitronectin
13%
Whole Genome Sequencing
6%
Wild Type
6%
